US 10513549
Cleavage-activatable interferon-alpha proprotein
granted A61KA61K38/00A61K47/64
Quick answer
US patent 10513549 (Cleavage-activatable interferon-alpha proprotein) held by CytomX Therapeutics, Inc. expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00, A61K47/64, A61K47/65, A61P